CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
cow's milk powder +1 moredrug
Likely dose
cow's milk powder 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00465569
NCT00465569Phase 2Completed
CompareCT.gov

A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy

Johns Hopkins University·interventional·Posted Apr 25, 2007·Updated Apr 20, 2017

In Brief

A Phase 2 clinical trial evaluating cow's milk powder and Placebo for Milk Hypersensitivity. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine if small oral doses of milk protein are safe and effective in decreasing sensitivity to cow's milk in allergic children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMilk Hypersensitivity
CountriesUnited States
CollaboratorsDuke University

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 25, 2007
Enrollment StartAug 1, 2006
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 19.2 years ago

Interventions

cow's milk powderdrug

Milk powder given orally in escalating doses to a goal of 500 mg for approximately 23 weeks

Placeboother